Evidence map›Paper›PMID 30284237›Full record

ArticleHealth services research2019

Medication adherence, costs, and ER visits of nurse practitioner and primary care physician patients: Evidence from three cohorts of Medicare beneficiaries.

Ulrike Muench, Chaoran Guo, Cindy Thomas, Jennifer Perloff

Abstract read
In one paragraph

Article in Health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Compliance with clinical guidelines: the role of incentives and competition between practitioners.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ulrike MuenchDepartment of Social and Behavioral Sciences, School of Nursing, University of California San Francisco, San Francisco, California.ORCID 0000-0003-0754-664X
Chaoran GuoDepartment of Economics, The Chinese University of Hong Kong, Hong Kong, China.
Cindy ThomasThe Heller School, Brandeis University, Waltham, Massachusetts.
Jennifer PerloffThe Heller School, Brandeis University, Waltham, Massachusetts.ORCID 0000-0003-1118-8734

Funding

National Council of State Boards of Nursing
6 · The paper itself

Abstract

objectiveTo compare medication adherence, cost, and utilization in Medicare beneficiaries attributed to nurse practitioners (NP) and primary care physicians (PCP). DATA: Medicare Part A, B, and D claims and beneficiary summary file data, years 2009-2013. STUDY

designWe used propensity score-weighted analyses combined with logistic regression and generalized estimating equations to test differences in good medication adherence (proportion of days covered (PDC >0.8); office-based and specialty care costs; and ER visits. DATA EXTRACTION: Beneficiaries with prescription claims for anti-diabetics, renin-angiotensin system antagonists (RASA), or statins. PRINCIPAL

findingsThere were no differences in good medication adherence (PDC >0.8) between NP and PCP attributed beneficiaries taking anti-diabetics or RASA. Beneficiaries taking statins had a slightly higher probability of good adherence when attributed to PCPs (74.6% vs 75.5%; P < 0.05). NP attributed beneficiaries had lower office-based and specialty care costs and were less likely to experience an ER visit across all three medication cohorts (P < 0.01).

conclusionsExamining the impact of NP and PCP provided care on outcomes beyond the primary care setting is important to the Medicare program in general but will also help practices seeking to meet benchmarks under alternative payment models that incentivize higher quality and lower costs.

Indexed as

Drug MonitoringCohort StudiesEmergency Service, HospitalFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsMaleMedicareNurse PractitionersPhysicians, Primary CareUnited StatesHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic Agentshealth care costsMedicareprimary care

Identifiers

PMID30284237
PMCPMC6338303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.